Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -7.18M
March 31, 2026 -6.998M
December 31, 2025 -6.921M
September 30, 2025 -7.057M
June 30, 2025 -7.613M
March 31, 2025 -7.646M
December 31, 2024 -8.538M
September 30, 2024 -8.905M
June 30, 2024 -9.395M
March 31, 2024 -10.13M
December 31, 2023 -10.51M
September 30, 2023 -10.08M
June 30, 2023 -10.26M
March 31, 2023 -10.51M
December 31, 2022 -10.66M
September 30, 2022 -11.42M
June 30, 2022 -10.42M
March 31, 2022 -9.767M
December 31, 2021 -8.907M
September 30, 2021 -8.386M
June 30, 2021 -7.735M
March 31, 2021 -6.765M
December 31, 2020 -6.147M
September 30, 2020 -5.206M
June 30, 2020 -5.052M
Date Value
March 31, 2020 -5.198M
December 31, 2019 -4.975M
September 30, 2019 -4.805M
June 30, 2019 -4.723M
March 31, 2019 -4.293M
December 31, 2018 -3.914M
September 30, 2018 -3.617M
June 30, 2018 -3.654M
March 31, 2018 -3.911M
December 31, 2017 -3.847M
September 30, 2017 -3.845M
June 30, 2017 -3.752M
March 31, 2017 -3.506M
December 31, 2016 -3.679M
September 30, 2016 -3.855M
June 30, 2016 -4.359M
March 31, 2016 -4.329M
December 31, 2015 -5.100M
September 30, 2015 -5.893M
June 30, 2015 -5.084M
March 31, 2015 -5.049M
December 31, 2014 -3.707M
September 30, 2014 -2.789M
June 30, 2014 -2.681M
March 31, 2014 -2.139M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Abbott Laboratories --
AngioDynamics, Inc. 3.673M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M
Baxter International, Inc. 1.319B